These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1394087)

  • 1. Quantitatively evaluated ultrastructural findings can add to the differential diagnosis between keratoacanthoma and well differentiated squamous cell carcinoma.
    Miracco C; De Santi MM; Lio R; Biagioli M; Tosi P; Luzi P
    J Submicrosc Cytol Pathol; 1992 Jul; 24(3):315-21. PubMed ID: 1394087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell apoptosis as assessed by M30 expression in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Brumini G; Biljan D; Petranović D; Troselj-Vukić B
    Coll Antropol; 2008 Jun; 32(2):499-504. PubMed ID: 18756900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen immunostaining in keratoacanthoma and squamous cell carcinoma of the skin.
    Royds JA; Stephenson TJ; Silcocks PB; Bleehen SS
    Pathologica; 1994 Dec; 86(6):612-6. PubMed ID: 7617390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma.
    Randall MB; Geisinger KR; Kute TE; Buss DH; Prichard RW
    Am J Clin Pathol; 1990 Feb; 93(2):259-62. PubMed ID: 2301286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
    Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
    Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry.
    Biesterfeld S; Josef J
    Anticancer Res; 2002; 22(5):3019-23. PubMed ID: 12530035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.
    Mukunyadzi P; Sanderson RD; Fan CY; Smoller BR
    Mod Pathol; 2002 Jan; 15(1):45-9. PubMed ID: 11796840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization.
    Cheville JC; Bromley C; Argenyi ZB
    J Cutan Pathol; 1995 Dec; 22(6):546-50. PubMed ID: 8835173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma.
    Beham A; Regauer S; Soyer HP; Beham-Schmid C
    Adv Anat Pathol; 1998 Sep; 5(5):269-80. PubMed ID: 10021894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratoacanthoma and infundibulocystic squamous cell carcinoma.
    Kossard S; Tan KB; Choy C
    Am J Dermatopathol; 2008 Apr; 30(2):127-34. PubMed ID: 18360115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
    Sakiz D; Turkmenoglu TT; Kabukcuoglu F
    Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratoacanthoma: facts and controversies.
    Ko CJ
    Clin Dermatol; 2010; 28(3):254-61. PubMed ID: 20541676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pseudo-epitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma occurring within tattoos: diagnostic issues.
    Kluger N; Plantier F
    J Am Acad Dermatol; 2007 Nov; 57(5):901-2. PubMed ID: 17939943
    [No Abstract]   [Full Text] [Related]  

  • 14. [Epidermoid carcinoma or keratoacanthoma?].
    Estruch R; Aguilera MT; Cardellach F; Palou J
    Med Clin (Barc); 1986 Oct; 87(11):477. PubMed ID: 3784650
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers.
    Slater M; Barden JA
    Histopathology; 2005 Aug; 47(2):170-8. PubMed ID: 16045778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of apoptotic and cell proliferation regulatory proteins in keratoacanthomas and squamous cell carcinomas of the skin.
    Ribeiro D; Narikawa S; Marques ME
    Pathol Res Pract; 2008; 204(2):97-104. PubMed ID: 18079070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eruptive squamous cell carcinomas, keratoacanthoma type, arising in a multicolor tattoo.
    Goldenberg G; Patel S; Patel MJ; Williford P; Sangueza O
    J Cutan Pathol; 2008 Jan; 35(1):62-4. PubMed ID: 18095997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic markers in the differential diagnosis of keratoacanthoma versus squamous cell carcinoma.
    Fernandez-Flores A
    Histopathology; 2007 Jan; 50(2):284-5. PubMed ID: 17222261
    [No Abstract]   [Full Text] [Related]  

  • 19. Stereological estimation of mean nuclear volume and staining pattern of Ki-67 antigen in keratoacanthomas and squamous cell carcinomas.
    Sağol O; Kurtoğlu B; Ozer E; Pabuççuoğlu U
    Gen Diagn Pathol; 1998 Apr; 143(5-6):305-9. PubMed ID: 9653912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Keratoacanthoma or carcinoma? Histological differential diagnosis].
    Hundeiker M
    Pathologe; 1979 Nov; 1(1):50-2. PubMed ID: 555520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.